Dental Bone Grafts and Substitutes Market Size & Growth Forecast 2027–2036, By Segments (End-use, Material Type, Application), Regional Demand Trends (North America, Asia Pacific, Europe), Key Country Insights (U.S., Japan, South Korea, Germany, France, Italy), and Competitive Landscape
Market Size and Growth Outlook
Dental Bone Grafts and Substitutes Market size was around USD 973.1 million in 2026 and is slated to grow at a 8.65% CAGR from 2027 to 2036, crossing USD 2.23 billion by 2036. The industry revenue for 2027 is estimated at USD 1.04 billion.
Get more details on this report
Request Free Sample ReportDental Bone Grafts and Substitutes Market Intelligence Snapshot
Regional Market Dynamics
- North America captured a 40.28% share in 2026 due to high implant procedure volumes, broad availability of advanced biomaterials, and established specialist dental networks supporting routine graft use.
- Asia Pacific is expected to expand at a 10.74% CAGR, driven by improving access to dental care, growing implant adoption, and wider availability of graft substitutes in urban dental centers.
Segment Momentum
- Dental clinics held a 73.25% share in 2026 because they perform most implant dentistry, periodontal grafting, and socket preservation procedures within specialized treatment workflows.
- Synthetic graft materials are expanding fastest as clinicians increasingly value standardized composition, consistent manufacturing quality, and reliable performance across a wider range of dental grafting procedures.
Market Expansion Drivers
- Rising volume of dental implant procedures driving demand for bone regeneration materials.
- Growing geriatric population increasing incidence of periodontal disease and tooth loss.
- Expanding dental tourism and lower-cost implant procedures boosting graft material adoption.
Leading Market Participants
- Prominent players in the dental bone grafts and substitutes market include Geistlich Pharma AG (Switzerland), Medtronic plc (Ireland), Zimmer Biomet Holdings, Inc. (USA), Dentsply Sirona Inc. (USA), Straumann Holding AG (Switzerland), Stryker Corporation (USA), Baxter International Inc. (USA), Smith & Nephew plc (UK), Envista Holdings Corporation (USA), BioHorizons (USA).
Global Market Forecast Snapshot
Market Outlook
- 2026 Market Size: USD 973.1 million
- 2027 Estimated Market Size: USD 1.04 billion.
- Projected Market Size: USD 2.23 billion by 2036
- Growth Forecast: 8.65% CAGR (2027-2036)
Regional and Segment Outlook
- Leading Regional Market: North America
- High-Growth Regional Hub: Asia Pacific
- Core Revenue Segment: Dental Clinics (End-use) | Xenograft (Material Type) | Socket Preservation (Application)
- Emerging Opportunity Segment: Hospitals (End-use) | Synthetic (Material Type) | Sinus Lift (Application)
Market Growth Drivers and Industry Trends
Rising volume of dental implant procedures driving demand for bone regeneration materials
The increasing use of dental implants is generating greater requirements for materials that can restore or augment insufficient bone structures, thereby driving the dental bone grafts and substitutes market. Implant placement often depends on adequate bone volume and quality, while patients with bone deficiencies may require grafting procedures before or alongside implant treatment. Bone graft materials and substitutes provide clinicians with options for supporting bone regeneration and preparing treatment sites for implant placement. As dental practices expand implant-based restorative care, demand is also increasing for biomaterials that can be selected according to defect characteristics, surgical requirements, and patient treatment plans.
Growing geriatric population increasing incidence of periodontal disease and tooth loss
An expanding older population is contributing to a higher prevalence of oral conditions associated with tooth loss and deterioration of supporting dental structures, supporting the dental bone grafts and substitutes market. Periodontal disease can damage the tissues and bone surrounding teeth, while age-related oral health challenges may increase the need for restorative and implant-based interventions. When tooth loss is accompanied by reduced jawbone volume, grafting materials can be used to support reconstruction and create suitable conditions for subsequent dental procedures. The growing need for comprehensive oral rehabilitation among older patients is therefore increasing the relevance of bone regeneration materials within dental treatment pathways.
Expanding dental tourism and lower-cost implant procedures boosting graft material adoption
The expansion of dental tourism is improving access to implant and restorative procedures in destinations where treatment costs can be comparatively lower, supporting adoption across the dental bone grafts and substitutes market. Patients traveling for dental care may undergo complex implant procedures that require bone augmentation or regeneration as part of the treatment process. The availability of specialized dental clinics and increasing cross-border demand for affordable restorative care can encourage broader use of grafting materials in implant treatment protocols. Dental providers serving these patient populations also require suitable biomaterials to manage different levels of bone deficiency and support implant placement procedures.
| Growth Driver | Impact on CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising volume of dental implant procedures driving demand for bone regeneration materials | 2.30% | High | North America, Europe, Asia Pacific | High | Near Term |
| Growing geriatric population increasing incidence of periodontal disease and tooth loss | 2.10% | High | North America, Europe | High | Near Term |
| Expanding dental tourism and lower-cost implant procedures boosting graft material adoption | 1.90% | Moderate | Asia Pacific, Latin America | Medium | Mid Term |
Unlock insights tailored to your business with our bespoke market research solutions.
Click to get your customized report now.
Regional Demand Dynamics
North America (Largest Region)
North America led the dental bone grafts and substitutes market with a 40.28% share in 2026, underpinned by advanced dental care infrastructure, high adoption of implant-based procedures, and strong demand for restorative and reconstructive treatments. Dental professionals increasingly rely on bone grafting materials to support implant placement and address bone deficiencies associated with tooth loss, trauma, and periodontal conditions. Continued improvements in biomaterials, regenerative techniques, and minimally invasive procedures are expanding clinical applications while supporting more predictable treatment outcomes. A well-established network of dental specialists and greater patient awareness of advanced oral rehabilitation are also contributing to adoption. At the same time, increasing emphasis on aesthetic outcomes and preservation of oral function is encouraging patients and providers to consider regenerative approaches as part of comprehensive dental treatment.
Asia Pacific (Fastest-Growing Region)
Asia Pacific represents the fastest-growing regional market, supported by expanding dental infrastructure, rising awareness of oral health, and increasing access to advanced restorative procedures. Growing healthcare expenditure and the development of private dental practices are creating new opportunities for implant dentistry and associated bone regeneration technologies. The region's large and increasingly urbanized population is also driving demand for treatments that address tooth loss and restore oral function, while greater awareness of dental aesthetics is supporting elective restorative care. Improvements in clinical training and wider availability of advanced dental materials are helping practitioners adopt modern grafting techniques. Expanding healthcare access, coupled with increasing acceptance of technologically advanced dental procedures, is strengthening the region's potential for sustained market development.
| Parameter | North America | Asia Pacific | Europe | Latin America | MEA |
|---|---|---|---|---|---|
| Innovation Hub i Scale Nascent Developing Advanced | |||||
| Cost-Sensitive Region i Scale Low Medium High | |||||
| Regulatory Environment i Scale Restrictive Neutral Supportive | |||||
| Demand Drivers i Scale Weak Moderate Strong | |||||
| Development Stage i Scale Emerging Developing Developed | |||||
| Adoption Rate i Scale Low Medium High | |||||
| New Entrants / Startups i Scale Sparse Moderate Dense | |||||
| Macro Indicators i Scale Weak Stable Strong |
Key Country Insights
Germany 🇩🇪
Regenerative Dentistry FocusGermany emphasizes high-quality dental bone graft materials that support predictable implant success and periodontal reconstruction. Dental professionals in Germany increasingly adopt biomaterials backed by clinical evidence and precision manufacturing standards for complex oral procedures.
France 🇫🇷
Clinical Biomaterial AdoptionFrance expands the use of dental bone graft substitutes across implantology and periodontal therapies requiring reliable tissue regeneration. French dental practices prioritize clinically validated materials that balance handling characteristics with long-term therapeutic performance.
Italy 🇮🇹
Restorative Procedure SupportItaly applies dental bone grafts and substitutes across implant restoration and reconstructive oral surgery. Italian clinicians increasingly favor biomaterials that simplify surgical procedures while supporting predictable bone regeneration in routine and advanced cases.
Japan 🇯🇵
Precision Grafting SolutionsJapan focuses on dental bone grafts that deliver consistent regenerative performance for an aging patient population seeking restorative treatments. Manufacturers in Japan continue refining synthetic and biologic substitutes that integrate efficiently into minimally invasive implant procedures.
South Korea 🇰🇷
Digital Implant IntegrationSouth Korea combines advanced implant dentistry with specialized bone graft materials to improve treatment outcomes. Dental providers in South Korea increasingly integrate regenerative products with digital diagnostics and guided surgical techniques for efficient clinical workflows.
United States 🇺🇸
Implant Procedure InnovationThe U.S. dental bone grafts and substitutes market is driven by increasing implant procedures and advanced regenerative dentistry. Clinics and manufacturers in the U.S. prioritize biomaterials with proven clinical outcomes, streamlined surgical workflows, and compatibility with digital treatment planning.
Segment Leadership and Growth Trends
Dental Bone Grafts and Substitutes Market Share (%), by End-use, 2026
Go beyond the chart, access full insights & data tables
Request Free Sample ReportEnd-use Segment Analysis: Dental Clinics (Largest Segment) vs Hospitals (Fastest-Growing Segment)
Dental clinics held the largest share of the dental bone grafts and substitutes market, accounting for 73.25% in 2026. Their dominant position reflects the high concentration of routine and specialized dental procedures requiring bone augmentation and restorative support within dedicated dental care settings. Dental clinics provide focused infrastructure and specialized expertise for procedures involving periodontal, implant-related, and reconstructive treatment. Increasing emphasis on restoring oral function and supporting successful dental interventions continues to sustain demand for grafting and substitute materials in these facilities.
Hospitals represent the fastest-growing end-use segment, supported by the increasing integration of complex dental and maxillofacial procedures within hospital-based care. Hospitals can provide multidisciplinary expertise, advanced surgical infrastructure, and comprehensive support for patients requiring more complex interventions. Greater demand for specialized treatment environments and coordinated care for patients with complicated clinical needs is contributing to the expanding use of dental bone grafts and substitutes in hospitals.
Material Type Segment Analysis: Xenograft (Largest Segment) vs Synthetic (Fastest-Growing Segment)
Xenograft materials dominated the dental bone grafts and substitutes market, representing a 51.09% share in 2026. Their established position is supported by widespread clinical use as bone grafting materials and their ability to provide a scaffold that supports bone regeneration. Xenografts offer clinicians an established material option for managing bone deficiencies associated with dental procedures, particularly where adequate bone volume is needed to support restorative treatment. Continued use of established grafting approaches supports their strong market presence.
Synthetic materials are experiencing the fastest growth, driven by increasing interest in engineered alternatives that can provide controlled and consistent characteristics for bone regeneration procedures. Synthetic grafts can be developed with tailored compositions and physical properties, offering flexibility for different clinical requirements. Ongoing material innovation and increasing interest in alternatives that can address availability, handling, and procedural considerations are supporting greater adoption of synthetic dental bone graft substitutes.
| Segment | Sub-Segment | Largest Segment | Fastest Growing |
|---|---|---|---|
| End-use | Hospitals, Dental Clinics | Dental Clinics | Hospitals |
| Material Type | Autograft, Allograft, Xenograft, Synthetic | Xenograft | Synthetic |
| Application | Ridge Augmentation, Sinus Lift, Periodontal Defect Regeneration, Implant Bone Regeneration, Socket Preservation | Socket Preservation | Sinus Lift |
Competitive Landscape and Market Positioning
Leading companies in the dental bone grafts and substitutes market:
1. Geistlich Pharma AG (Switzerland)
2. Medtronic plc (Ireland)
3. Zimmer Biomet Holdings Inc. (USA)
4. Dentsply Sirona Inc. (USA)
5. Straumann Holding AG (Switzerland)
6. Stryker Corporation (USA)
7. Baxter International Inc. (USA)
8. Smith & Nephew plc (UK)
9. Envista Holdings Corporation (USA)
10. BioHorizons (USA)
The dental bone grafts and substitutes market is advancing with improved biomaterial integration and regenerative dental solutions. Innovations are enhancing compatibility and healing efficiency in clinical procedures. The dental bone grafts and substitutes market continues to grow due to increasing demand for advanced oral reconstruction techniques.
| Company | Market Share | Company Revenue | Revenue CAGR (%) | Product Portfolio | Geographic Presence | Innovation / R&D Focus | Strategic Developments |
|---|---|---|---|---|---|---|---|
| Geistlich Pharma AG (Switzerland) | |||||||
| Medtronic plc (Ireland) | |||||||
| Zimmer Biomet Holdings Inc. (USA) | |||||||
| Dentsply Sirona Inc. (USA) | |||||||
| Straumann Holding AG (Switzerland) | |||||||
| Stryker Corporation (USA) | |||||||
| Baxter International Inc. (USA) | |||||||
| Smith & Nephew plc (UK) | |||||||
| Envista Holdings Corporation (USA) | |||||||
| BioHorizons (USA). |
Industry Development/News
| Company Name | Date | Key Development |
|---|---|---|
| LifeNet Health | Feb-26 | LifeNet Health developed OraGen, a viable dental bone allograft product composed of cryopreserved corticocancellous bone with demineralized bone matrix and viable cells. The product is designed to enhance osteogenic, osteoconductive, and osteoinductive performance, supporting improved clinical outcomes in dental reconstruction and regenerative bone grafting procedures. |
| Geistlich | Nov-25 | Geistlich introduced Geistlich Bio-Gide Forte, a bone regeneration membrane designed with improved firmness to enhance handling during surgical procedures. The company also announced a flowable version of Geistlich Bio-Oss scheduled for 2026, intended to streamline application in bone regeneration workflows through improved material handling and combined collagen-based formulation characteristics. |
| Orthofix Medical Inc. | Oct-23 | Orthofix Medical Inc. commercially launched OsteoCove, an advanced bioactive synthetic bone graft available in putty and strip formats. The product expansion enhances the company’s regenerative biomaterials portfolio, supporting broader clinical applications in bone repair procedures and strengthening its competitive positioning in synthetic graft solutions. |
| BONESUPPORT | Jul-23 | BONESUPPORT launched CERAMENT G, a next-generation antibiotic-eluting bone graft substitute featuring enhanced surface sterility. The product strengthens infection-control capabilities in bone regeneration applications and expands the company’s offering in advanced synthetic graft solutions designed for orthopedic and dental reconstructive procedures. |
| ZimVie Inc. | Apr-23 | ZimVie Inc. launched RegenerOss CC Allograft and RegenerOss Bone Graft Plug in North America for dental applications. The introduction expands the company’s regenerative product portfolio and strengthens its positioning in dental bone grafting solutions by broadening clinically usable allograft formats for reconstructive and implant-related procedures. |
| MTF Biologics | Mar-22 | MTF Biologics entered a distribution partnership with Bone Biologics Corporation to commercialize demineralized bone matrix products. The collaboration enhances market access for bone graft materials and strengthens distribution capabilities for biologic graft substitutes across clinical applications in regenerative bone and reconstructive procedures. |
| Orthofix Medical Inc. | Feb-22 | Orthofix Medical Inc. launched Opus BA, a synthetic bioactive bone graft solution designed for cervical and lumbar spine fusion procedures. The product expands the company’s synthetic graft portfolio and strengthens its position in regenerative biomaterials used in spinal and orthopedic reconstruction applications. |
| AlloSource | Oct-21 | AlloSource launched AlloMend Extra-Large (XL) Acellular Dermal Matrix as an extension of its AlloMend product line. The expansion enhances the company’s regenerative tissue portfolio and supports broader clinical use in soft tissue and reconstructive procedures, strengthening its position in biologic graft solutions. |
| Orthofix Holdings, Inc. | Jul-21 | Orthofix Holdings, Inc. launched fiberFUSE Strip, a demineralized fiber bone graft solution incorporating cancellous bone for enhanced regenerative performance. The product introduction expands its bone graft portfolio and supports broader adoption in reconstructive procedures requiring advanced structural and biologic integration. |
| GRAFTYS | Dec-20 | GRAFTYS achieved CE recertification and MDSAP certification across multiple regions, including Brazil, Australia, and the United States, for its sterile calcium phosphate-based bone graft substitutes. These certifications reinforce regulatory compliance and support continued commercialization of its bioresorbable graft portfolio across key international medical device markets. |
| GreenBone Ortho | Feb-20 | GreenBone Ortho received CE Mark approval for its GreenBone Substitute, a naturally derived bone graft material produced from rattan wood. The regulatory clearance enables commercialization in European markets and expands the availability of alternative biomaterial-based graft substitutes for bone regeneration applications. |
Customize Your Report
Explore examples of how this report can be tailored to different research needs, including custom segments, additional topics or chapters, and related reports. Click a section of the wheel or its numbered marker to explore the available options.
Dental Bone Grafts and Substitutes Market — Custom Segments
| Segment | Sub-Segment |
|---|---|
| Patient Age Group | Pediatric Patients, Adult Patients, Geriatric Patients |
| Procurement Model | Direct Purchase, Group Purchasing Organizations, Distributor-Mediated Procurement |
| Clinical Procedure Complexity | Routine Procedures, Moderate-Complexity Procedures, Advanced/Reconstructive Procedures |
Dental Bone Grafts and Substitutes Market — Custom TOC
| Custom Chapter | Custom Details |
|---|---|
| Dental Implant Procedure and Clinical Application Opportunities |
|
| Biomaterial Adoption and Regenerative Dentistry Opportunities |
|
| Dental Practice Procurement and Patient Access Dynamics |
|
Need a different cut of the data?
Request Custom ResearchHow large is the dental bone grafts and substitutes market?
How is the dental bone grafts and substitutes industry projected to perform over the next decade?
How is the growth of implant dentistry influencing demand in the Dental Bone Grafts and Substitutes Market?
Why are synthetic graft materials gaining momentum in the Dental Bone Grafts and Substitutes Market?
Why do dental clinics lead the dental bone grafts and substitutes market?
Why are synthetic materials the fastest-growing segment in the dental bone grafts and substitutes market?
Why is North America the leading regional market for dental bone grafts and substitutes?
What factors are accelerating growth in the Asia Pacific dental bone grafts and substitutes market?
Who holds a significant market share in the dental bone grafts and substitutes landscape?
Our Clients
"The team took the time to understand our specific business needs and delivered a report that was well aligned with our objectives. Their expertise and understanding of the industry were clearly reflected in the quality and relevance of the insights provided."
Siemens Healthcare
"Our experience in acquiring the research report has been excellent. The depth of analysis, and actionable insights provided have been extremely valuable in supporting our ongoing R&D efforts."
GC Biopharma
"The report offered a comprehensive view of the market trends. The in-depth segmentation and analysis of emerging opportunities gave us a better understanding of the market."
Medtronic
Our Research Team & Methodology
Every Fundamental Business Insights report is built by a dedicated vertical research team, validated through a structured primary-and-secondary methodology, and reviewed for accuracy before it reaches you.
Research Team Overview
Prepared by the Healthcare & Medical Devices Research Team
Delivery
Published
Demand
Available
Support
Trust & Compliance
Research Domains
10 coverage areasResearch Intelligence
| Source | Reference |
|---|---|
| World Health Organization (WHO) | www.who.int |
| U.S. Food & Drug Administration (FDA) | www.fda.gov |
| European Medicines Agency (EMA) | www.ema.europa.eu |
| Centers for Disease Control and Prevention (CDC) | www.cdc.gov |
| National Institutes of Health (NIH) | www.nih.gov |
| National Center for Biotechnology Information (NCBI) | www.ncbi.nlm.nih.gov |
| PubMed | pubmed.ncbi.nlm.nih.gov |
| ClinicalTrials.gov | clinicaltrials.gov |
| International Organization for Standardization (ISO) | www.iso.org |
| ASTM International | www.astm.org |
| Advanced Medical Technology Association (AdvaMed) | www.advamed.org |
| Medical Device Innovation Consortium (MDIC) | mdic.org |
| Biotechnology Innovation Organization (BIO) | www.bio.org |
| International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) | www.ifpma.org |
| U.S. Pharmacopeia (USP) | www.usp.org |
| European Directorate for the Quality of Medicines & HealthCare (EDQM) | www.edqm.eu |
| World Organisation for Animal Health (WOAH) | www.woah.org |
| American Hospital Association (AHA) | www.aha.org |
| OECD Health | www.oecd.org/health |
| World Bank Data | data.worldbank.org |
Research Workflow & Quality Assurance
Data Collection
Verified information gathered through primary and secondary research.
Data Triangulation
Cross-validation using multiple independent data sources.
Forecast Modelling
Market estimates developed using historical trends and analytical models.
Analyst Validation
Findings reviewed by domain experts for accuracy and consistency.
Editorial & Quality Review
Final editorial, quality, and compliance checks before publication.
Final Publication
Released after successful completion of the internal review process.
Report Coverage
📊 Market Assessment
- Market Size & Forecast
- Market Segmentation
- Regional Analysis
- Growth Drivers & Challenges
- Market Dynamics
🏢 Competitive Intelligence
- Competitive Landscape
- Company Profiles
- Competitive Benchmarking
- Mergers & Acquisitions
- Market Share Analysis or Key Company Strategies
🔍 Strategic Analysis
- Value Chain Analysis
- Porter's Five Forces
- PESTLE Analysis
- Pricing Trends
- Supply-Demand Analysis
🚀 Future Outlook
- Technology Landscape
- Regulatory Landscape
- Investment & Funding Landscape
- Emerging Opportunities
- Future Market Outlook
Have a question about this report or need a custom scope?
Request Customization